THROMBOZYTENTESTVERFAHREN

European patent · EP2352025 · In force

Register entry

Publication number
EP2352025
Application number
EP09806724
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Aug 11, 2009
Published
Aug 3, 2011
Granted
Jul 15, 2020
Protection ends at the latest
Aug 10, 2029
Next annual fee due
Aug 31, 2026
IPC classes
G01N 33/49 (2006.01)
G01N 33/86 (2006.01)
B01L 3/00 (2006.01)
Priority
JP 2008207389 11.08.2008
JP 2008330222 25.12.2008
PCT application
PCT/JP2009/064202 11.08.2009
PCT publication
WO2010/018833 18.02.2010
Filing language
Japanese
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Sep 1, 2025

    Change

    Published in Swissreg on 01.09.2025

  2. Sep 1, 2024

    Change

    Published in Swissreg on 01.09.2024

  3. Sep 1, 2023

    Change

    Published in Swissreg on 01.09.2023

  4. May 8, 2023

    Address changed

    Representative
    Valipat S.A., c/o BOVARD SA Neuchâtel, Rue des Noyers 11, 2000 Neuchâtel → VALIPAT, c/o BOVARD LTD, Optingenstrasse 16, 3013 Bern

    Published in Swissreg on 08.05.2023

  5. Sep 1, 2022

    Change

    Published in Swissreg on 01.09.2022

  6. Jul 21, 2020

    Agent entered

    Representative
    Valipat S.A., c/o BOVARD SA Neuchâtel, Rue des Noyers 11, 2000 Neuchâtel

    Published in Swissreg on 21.07.2020

  7. Jul 15, 2020

    Granted

    Published in Swissreg on 15.07.2020

Parties

Holder

Fujimori Kogyo Co., Ltd

FUJIMORI KOGYO CO., LTD.

1-23-7, Nishi-Shinjuku Shinjuku-ku, Tokyo 160-0023, JP

Agent

VALIPAT c/o BOVARD LTD

Optingenstrasse 16, 3013 Bern

Inventor

HOSOKAWA, Kazuya

Tokyo 160-0023, JP

FUKASAWA, Masashi

Tokyo 160-0023, JP

GONDA, Maki

Tokyo 160-0023, JP

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.